Dirui Industrial Co (300396) Q4 2025 earnings summary

Executive summary

• Reported a significant net loss for 2025, reversing from profit in 2024, mainly due to intensified domestic competition, policy impacts, and large asset impairment provisions.

• Domestic revenue dropped sharply by 40.31% year-over-year, while international revenue grew 16.37%.

• Auditor issued a qualified opinion on financial statements and an adverse opinion on internal controls due to sales contract irregularities and revenue recognition errors.

• No cash dividend, bonus shares, or capital increase from reserves for 2025 due to losses.

Financial highlights

• 2025 revenue: ¥807.06 million, down 17.41% year-over-year.

• Net loss attributable to shareholders: -¥245.99 million, compared to ¥65.16 million profit in 2024.

• Operating cash flow: ¥38.80 million, up 113.16% year-over-year due to lower procurement and labor costs.

• Gross margin for reagents: 61.67%; for instruments: 13.88%.

• Asset impairment losses: ¥213.64 million, mainly inventory write-downs.

• Basic and diluted EPS: -0.90 yuan.

• Total assets at year-end: ¥2.77 billion, down 17.74% from prior year.

• Net assets: ¥1.54 billion, down 17.18% year-over-year.

Outlook and guidance

• 2026 strategy focuses on risk mitigation, internal control rectification, and stabilizing operations.

• International business to deepen local market penetration and expand sales channels, emphasizing compliance and sustainable growth.

• Domestic business to focus on high-quality terminal installations, sales efficiency, and adapting to policy changes.

• R&D to accelerate new product launches, enhance AI-driven diagnostics, and strengthen industry collaborations.